ENABLE project video

Latvian Institute of Organic Synthesis is a member of the ENABLE consortium since 2014.

The ENABLE consortium is working to advance the development of promising new antibiotic compounds targeting Gram-negative bacteria such as Escherichia coli. The goal of the project is to develop attractive antimicrobial candidates for extensive preclinical studies and First-in-Human clinical trials, bringing new antibiotics to treat Gram-negative infections one step closer to patients.

The video introduces ENABLE, its drug discovery platform, expert network and explains how to submit an Expression of Interest (EoI).


Learn more about ENABLE project